Safety and Efficacy of Sofosbuvir-based Regimens in Clinical Practice for the Treatment of Chronic Hepatitis C Virus Infection in India

• Status: Completed
• Trial end date: 2018-04-23
• Target enrollment: 0
• Participant gender: All

Summary

This study will evaluate the safety and efficacy of sofosbuvir (SOF)-based regimens administered as per the approved prescribing information in adults with chronic hepatitis C virus (HCV) infection treated in routine clinical practice in India.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Gilead Sciences
• Treatments: Sofosbuvir

Criteria

Inclusion Criteria:

• HCV-infected patients living in India

• Treatment with a SOF-based regimen as determined by the patient's treating physician per the approved prescribing information.

• Patients who provide written and signed informed consent prior to initiation of treatment where required.

Exclusion Criteria:

• Concurrent participation in an HCV clinical trial (except trials not testing investigational medicinal products)

• Patients presenting a risk of not being able to be followed (eg, patients planning to move or leave the country in a foreseeable future)